The UK Life Sciences 10-year strategy aims to build on the response to COVID and use this as a blueprint to accelerate innovations in therapeutics and diagnostics to drastically improve patient outcomes. Specific missions will focus on dementia, cancer, vaccines discovery, obesity, respiratory disease, ageing and mental health.
Achieving this will rely upon building a solid infrastructure for industry, academia, government, charities and NHS to all work together, as well as strategies, including access to finance and efficient regulation, that UK healthcare companies can use to grow successfully.
Through an open Q&A session and polls, our BioWednesday Webinar will discuss this bold new vision, the preconditions for its success and what challenges may lie ahead in achieving it.
Copyright © 2023 Stevenage Bioscience Catalyst